SOUTHERNHAY HOUSE SURGERY — All Prescriptions & Medications — Page 2
Practice Code: L83058 | EXETER, EX1 1RX
Showing results 51-100 of 574
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Melatonin | 773 | 37.3K | £6.4K | +132.5% ▲ |
| Gabapentin | 772 | 94.4K | £2.4K | -22.7% ▼ |
| Indapamide | 762 | 24.3K | £741 | -11.6% ▼ |
| Olanzapine | 760 | 13.7K | £1.4K | +105.2% ▲ |
| Doxycycline hyclate | 739 | 6,777 | £712 | +44.2% ▲ |
| Ferrous fumarate | 703 | 34.5K | £1.5K | -3.0% ▼ |
| Oxycodone hydrochloride | 671 | 134.2K | £11.1K | +162.2% ▲ |
| Prednisolone | 668 | 32.7K | £1.1K | -16.4% ▼ |
| Thiamine hydrochloride | 655 | 19.1K | £529 | +24.3% ▲ |
| Isosorbide mononitrate | 635 | 20.0K | £3.5K | -3.9% ▼ |
| Glucose blood testing reagents | 634 | 67.1K | £9.4K | -19.7% ▼ |
| Dapagliflozin | 630 | 18.8K | £23.3K | -49.7% ▼ |
| Montelukast | 620 | 11.6K | £618 | -9.5% ▼ |
| Estradiol | 603 | 40.3K | £6.4K | -26.5% ▼ |
| Tiotropium bromide | 600 | 10.4K | £14.7K | +97.3% ▲ |
| Budesonide | 578 | 811 | £19.8K | +6.6% ▲ |
| Co-codamol (Codeine phosphate/paracetamol) | 556 | 58.0K | £2.6K | -71.6% ▼ |
| Carbocisteine | 543 | 53.2K | £1.7K | +1.7% vs avg |
| Sildenafil (Erectile Dysfunction) | 539 | 3,869 | £545 | +6.9% ▲ |
| Other emollient preparations | 536 | 278.0K | £3.6K | -10.8% ▼ |
| Cetirizine hydrochloride | 533 | 21.8K | £700 | +6.7% ▲ |
| Bendroflumethiazide | 528 | 16.8K | £282 | -31.7% ▼ |
| Losartan potassium | 515 | 17.7K | £523 | -70.9% ▼ |
| Methotrexate | 510 | 10.3K | £643 | +56.7% ▲ |
| Fexofenadine hydrochloride | 494 | 12.8K | £571 | -41.9% ▼ |
| 493 | 1,034 | £34.9K | -9.5% ▼ | |
| Warfarin sodium | 492 | 30.5K | £1.0K | +4.3% ▲ |
| 478 | 7,590 | £4.1K | -28.0% ▼ | |
| Digoxin | 469 | 10.6K | £781 | +23.9% ▲ |
| Alginic acid compound preparations | 465 | 240.2K | £2.7K | -20.6% ▼ |
| Famotidine | 461 | 12.2K | £7.3K | -5.5% ▼ |
| Rivaroxaban | 461 | 13.2K | £8.9K | -24.7% ▼ |
| Spironolactone | 458 | 10.9K | £1.1K | -15.1% ▼ |
| Fluticasone propionate (Inhalation) | 445 | 510 | £8.8K | +15.0% ▲ |
| Isophane insulin | 441 | 3,307 | £15.5K | +317.7% ▲ |
| Solifenacin | 437 | 9,906 | £398 | -8.4% ▼ |
| Canagliflozin | 424 | 9,562 | £11.9K | +195.3% ▲ |
| Desogestrel | 421 | 49.1K | £1.4K | +6.2% ▲ |
| Sodium valproate | 416 | 76.3K | £5.9K | +30.8% ▲ |
| Aripiprazole | 412 | 10.6K | £1.7K | +61.9% ▲ |
| Betamethasone valerate | 412 | 32.8K | £1.6K | +7.0% ▲ |
| Buprenorphine | 411 | 2,192 | £6.2K | +12.2% ▲ |
| Amoxicillin | 397 | 20.7K | £555 | -57.4% ▼ |
| Prochlorperazine maleate | 396 | 16.2K | £1.0K | +95.9% ▲ |
| Rosuvastatin calcium | 388 | 13.0K | £853 | -56.8% ▼ |
| Hydrocortisone | 384 | 12.2K | £1.7K | -14.4% ▼ |
| Other multivitamin preparations | 383 | 9,953 | £3.2K | +121.6% ▲ |
| Loratadine | 382 | 15.9K | £356 | +82.8% ▲ |
| Senna | 381 | 18.4K | £415 | -36.7% ▼ |
| Loperamide hydrochloride | 377 | 23.1K | £596 | +61.9% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.